Matthews South

Matthews South

  • About Us
  • Our Solutions
    • Debt
    • Equity
    • IPO
    • Pre-IPO Financing
    • Convertible & Call Spread
      • Call Spread Unwind
      • Liability Management
    • Share Repurchases
      • Accelerated Share Repurchase (ASR)
      • Enhanced Open Market Repurchase (eOMR)
    • Capital Structure Review
  • Our Clients
    • Client List
    • Testimonials
  • Our Team
  • Video Library
  • Blog
  • Contact Us
  • Login

Agios Pharmaceuticals

by | August 1, 2022 | Buyback, eOMR

“Matthews South was instrumental in the execution of our capital return program that included a privately negotiated buyback and Matthews South’s eOMR. They helped us with fair value analysis of the various private buyback structures, which informed and empowered our negotiations. Matthews South flawlessly executed our eOMR achieving a significant VWAP discount. We loved the cost saving in their program because there is no outperformance fee allowing us to retain almost all the VWAP discount generated. Significantly, their program provided the flexibility to work with any broker of our choice. I would also highlight the analytics they provided to help us set the program parameters, the useful detailed weekly reporting while the program was on-going, and the team’s overall responsiveness, all of which allowed my team to learn and grow from the engagement.”

Filed Under: Buyback, eOMR

Contact Us

To learn more about our solutions or to schedule a demo of our software, please contact us by filling out the form below, or email us at info@matthewssouth.com.






    • Matthews South LLC is a member of FINRA and SIPC
    • Brokercheck
    • © Matthews South, Inc. 2024
    • Privacy Policy
    • Additional Disclosure
    • Testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success